title: Treatment of leukemia patients with T101 ricin A chain immunotoxins.
authors.forename: G
authors.initials: G
authors.lastname: Laurent
authors.forename: A E
authors.initials: AE
authors.lastname: Frankel
authors.forename: A A
authors.initials: AA
authors.lastname: Hertler
authors.forename: D M
authors.initials: DM
authors.lastname: Schlossman
authors.forename: P
authors.initials: P
authors.lastname: Casellas
authors.forename: F K
authors.initials: FK
authors.lastname: Jansen
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use; D000943:Antigens, Differentiation / Q000276:immunology*; D018956:CD5 Antigens; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009360:Neoplastic Cells, Circulating; D012276:Ricin / Q000627:therapeutic use*
chemical_list: D000911:Antibodies, Monoclonal; D000943:Antigens, Differentiation; D018956:CD5 Antigens; D000922:Immunotoxins; D012276:Ricin